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Abstract: History of AMR surveillance in Kenya goes back to
late 1970s and early 80s when Kenyatta National Hospital and Uni-
versity of Nairobi, College of Health Sciences began compiling and
following antibiotic susceptibility patterns of routine clinical iso-
lates. 5th ICID held in Nairobi in 1992 gave birth to ICAK (infection
Control Association of Kenya) composed of pathologists, pharma-
cologists and nurses. Hospitals appointed IPC committees around
the same time under WHO guidance. Lab based AMR surveillance
was an IPC activity at that time. Except the national referral hos-
pital and a few small private hospitals in Nairobi, hospitals cannot
generate AMR data due to absence of microbiology labs. Almost
all AMR data is generated by scientists of Kenya Medical Research
Institute or other externally funded international research groups.
Most of these projects focus on organism based AMR since they
are proposed by scientists. There are no updates on AMR in clin-
ical conditions like meningitis, pneumonia or bacteremia in the
community due to lack of local funding support. Recognition of
diagnostic laboratory capacity as an essential component of health
care system for effective disease surveillance and control- was still
lacking at national level until the release of WHO white paper in
2008 declaring public health labs in Africa a top priority for fund-
ing. World Bank sponsored East African Public Health Laboratory
Network (EAPHLN) Project covering Kenya, Tanzania, Uganda and
Rwanda; ASM and CDC supported Lab Cap program are two bright
examples. The Launch of GARP Kenya project in 2009 and com-
pilation of situation analysis in 2011 are important mile stones
since this project brought together various professionals across the
country and establishment of AMR focal person and IPC secretariat
in the Ministry of Health. World health assembly resolution on
AMR in 2014 paved way to development of W H O global action
plan on AMR in 2015 which urged member states to make National
action plans for dealing with AMR. Kenya is well prepared to face
the challenge of AMR. EAPH Lab network is able to provide the
infrastructure for AMR surveillance. Close partnerships between
technical and clinical professionals and strong ﬁnancial support
from Local and National health care managers are crucial.
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Abstract: For the last two decades, health has been a high
priority in Mozambique. Although antibiotic resistance was not
a major focus, many of the measures taken, by the Mozambique
government, will have helped preserve the effectiveness of antibi-
otics. These include reducing the burden of infectious disease
by introducing new vaccines in the national immunization pro-
gram, building health infrastructure in rural settings, increasing the
paramedical and medical workforce at the district level, deploy-
ing community health workers in remote underserved settings,
adopting Integrated Management of Childhood Illness (IMCI) in
basic health facilities and encouraging the establishment of private
pharmacies in the rural areas where most of the population lives.
Mozambique was early among African countries to begin hospital
infection control andpreventionprogramsand tomonitorhospital-
acquired infections. Recognizing the problem of drug quality in
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Africa, a national laboratory for drug quality was built and well
equipped.
Global Antibiotic resistance partnership (GARP) provided a
framework to bring together many of the leaders of the programs
that form components of a national antibiotic resistance plan. The
GARP Mozambique working group brought them together with
a shared purpose, including both veterinary and human health
specialists including civil society ou consumer association. The
development of the situation analysiswas key to creating anational
focus on antibiotic resistance,whichhas resulted in appointment of
a focal person at the National Directorate of Health Care. It has also
sparked collaboration of the Ministries of Health and Agriculture, a
greater interest among students and researchers to ﬁll information
gaps, the beginning of AMR surveillance in three regions, and the
development of a National Action Plan on antibiotic resistance. The
seeds of this movement already existed in Mozambique and the
development would have taken place eventually, but GARP accel-
erated progress and provided signiﬁcant support as Mozambique
has become part of a growing network.
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Abstract: TheGlobalAntibiotic ResistancePartnership (GARP) is
a project started by the Center for Disease Dynamics, Economics &
Policy in 2008, with funding from the Bill & Melinda Gates Founda-
tion. GARP now includes eight low- and middle-income countries,
including the ones represented in this session, and is set to expand
further in Africa and Asia. The GARP model involves bringing
together professionals already expert in aspects of antimicrobial
resistance (AMR), and covering both human and animal antibi-
otic use and resistance in what we have called “working groups.”
Although the working groups are free standing and uncompen-
sated, where possible, they include representation from Ministries
of Health and Agriculture. These groups become a national brain
trust on AMR, working collaboratively with government. We have
learned that this is a way for low-resource countries to start on
an evidence-based path to national AMR plans without an initial
government investment. A key tool that we have required working
groups to produce is a situation analysis that includes all available
(published and unpublished) information on antibiotic resistance
in humans and animals in the country, enriched by contextual
information, such as the burden of antibiotic-treatable disease in
the country, the supply chain for antibiotics, access to antibiotics
among the population, etc. Important to completing the situation
analysis has been the requirement of a paid working group coor-
dinator, in all cases a young professional, which brings the added
beneﬁt of capacity building. Building up to national AMRplansmay
take several years in countries that have not started the process,
but the global imperative now evident may help to shorten that
timeline. The GARP process of relying on local leadership through
a working group is one model that has been successful and is avail-
able for other countries to borrow and improve upon.
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